Wolfe Research analyst Alex Zukin maintains ZoomInfo Technologies (NASDAQ:ZI) with a Outperform and lowers the price target from $65 to $50.
Citigroup Maintains Neutral on ACADIA Pharmaceuticals, Raises Price Target to $19.4
Citigroup analyst Neena Bitritto-Garg maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Neutral and raises the price target from $19 to $19.4.